# EDGAR Filing Document

**Accession Number:** 0001607962
**File Stem:** 0001178913-26-002212
**Filing Date:** 2026-4
**Character Count:** 4946
**Document Hash:** 2932dc046373648c96d4be4c8c442b15
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-26-002212.hdr.sgml**: 20260423

**ACCESSION NUMBER**: 0001178913-26-002212

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260420

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20260423

**DATE AS OF CHANGE**: 20260423

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lifeward Ltd.
- **CENTRAL INDEX KEY:** 0001607962
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36612
- **FILM NUMBER:** 26888846

**BUSINESS ADDRESS:**
- **STREET 1:** 2 CABOT ROAD
- **CITY:** HUDSON
- **STATE:** MA
- **ZIP:** 01749
- **BUSINESS PHONE:** 15082511154

**MAIL ADDRESS:**
- **STREET 1:** 2 CABOT ROAD
- **CITY:** HUDSON
- **STATE:** MA
- **ZIP:** 01749

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ReWalk Robotics Ltd.
- **DATE OF NAME CHANGE:** 20140620

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Argo Medical Technologies Ltd.
- **DATE OF NAME CHANGE:** 20140513

?xml version='1.0' encoding='ASCII'?

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 20, 2026

Lifeward Ltd.

------

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Israel**<br>| **001-36612**<br>| **Not applicable**<br>|
| **(State or other jurisdiction of incorporation or organization)**  | **(Commission File Number)**  | **(IRS Employer Identification No.)**  |

---

---

| | |
|:---|:---|
| **2 Cabot Rd., Hudson, MA**<br>| **01749**<br>|
| **(Address of principal executive offices)** | (Zip Code) |

---

Registrant's telephone number, including area code: +508.251.1154

#### Not Applicable (Former name or former address, if changed since last report)

**Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

Securities registered pursuant to Section 12(b) of the Act:**

**<u> Title of each class </u> <u> Trading Symbol </u> <u> Name of each exchange on which registered </u> <br> Ordinary Shares, no par value LFWD Nasdaq Capital Market**

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

#### Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' Compensatory Arrangements of Certain Officers.
Pursuant to notice provided on April 20, 2026, Jeannine Lynch's employment with Lifeward Ltd. (the "Company") as the Vice President of Strategy and Market Access will be terminated, effective May 3, 2026. Ms. Lynch's departure will be treated as a termination without cause pursuant to the terms of her Employment Agreement, dated July 9, 2021 (the "Employment Agreement"). Ms. Lynch will receive severance and other benefits in accordance with the terms of her Employment Agreement. The terms of the Employment Agreement were disclosed in the Company's Annual Report on Form 10-K, which was filed with the U.S. Securities and Exchange Commission on March 18, 2026.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Lifeward Ltd.** | **Lifeward Ltd.** |
| Dated: April 23, 2026 | By: | /s/ Almog Adar |
|  | Name: | Almog Adar |
|  | Title: | Chief Financial Officer |

---

------